Document Detail


Assessment of growth hormone secretion: what are we looking for practically?
MedLine Citation:
PMID:  2245964     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
GH is a dominant factor in determining growth during childhood. Hence, the assessment of GH secretion is of major importance in the diagnosis of growth disorders. Since GH is secreted in a pulsatile fashion, a truly accurate production rate can only be calculated by using very frequent or continuous blood sampling over a 24-hour period. Several standard provocative tests have been established to evaluate GH secretory status. They remain the cornerstone in the assessment. Recent data have shown the existence of a wide spectrum of GH secretory disturbances ranging from severe GH deficiency to partial insufficiency and neurosecretory dysfunction. There is no well-defined cut-off point at which a particular child can be regarded as GH insufficient or sufficient for optimal growth. In clinical practice, the assessment of GH secretion starts with the careful analysis of the growth chart and height velocity. Careful clinical examination of the patient is essential for the proper diagnosis, and to exclude diseases influencing GH secretion. Additional biochemical tests may be required for the differential diagnosis. Thus, assessment of GH secretion in children requires auxological, clinical and biochemical data. GH insufficiency is documented by additional testing of pituitary secretory capacity either by standard provocative tests, by studying 24-hour GH profile or by measuring 24-hour production rate. The main goal is to detect those children who will benefit from treatment with hGH. The final assessment might consist in the response of growth velocity to exogenous hGH.
Authors:
M Vanderschueren-Lodeweyckx
Related Documents :
19729944 - Diagnosis of growth hormone deficiency by using the arginine provocative test: is it po...
4031384 - Lack of effect of im diazepam administration on hgh and hprl secretion in normal and ac...
17878604 - A case of addison's disease confirmed with low dose cosyntropin stimulation test.
15333194 - Morning salivary cortisol versus short synacthen test as a test of adrenal suppression.
19062074 - Are victoria west cores "proto-levallois"? a phylogenetic assessment.
3880224 - Laboratory evaluation of controlled-release insect repellent formulations.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Hormone research     Volume:  33 Suppl 4     ISSN:  0301-0163     ISO Abbreviation:  Horm. Res.     Publication Date:  1990  
Date Detail:
Created Date:  1991-01-07     Completed Date:  1991-01-07     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0366126     Medline TA:  Horm Res     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  1-6     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, University of Leuven, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Growth Disorders / diagnosis*
Growth Hormone / deficiency,  physiology,  secretion*
Humans
Pituitary Gland / secretion
Chemical
Reg. No./Substance:
9002-72-6/Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities
Next Document:  Measurement of urinary growth hormone. A noninvasive method to assess the 'growth hormone status'.